Clinical trials management
ICON plans and runs clinical trials for new drugs, devices, and other therapies. It helps with study setup, site management, patient monitoring, and trial oversight.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
ICON PLC is a contract research organization that helps drugmakers and medical device companies run clinical trials. It plans and manages studies, recruits patients, collects and analyzes trial data, and helps customers navigate the regulatory steps needed to test new treatments. The company also offers lab and data services that support drug development from early testing through late-stage trials.
Its main customers are pharmaceutical companies, biotech firms, and medical device makers that want to outsource part or all of the development process. ICON earns money by charging for study management, monitoring, data handling, laboratory work, and related services under client contracts. In practice, it acts as an outside partner that helps customers move products through the long, expensive process of proving safety and effectiveness.
What makes ICON's business different is its role in the middle of the healthcare development chain. It does not sell medicines itself; instead, it sells specialized expertise, trial infrastructure, and scientific services that many life-science companies need but do not want to build in-house. That makes ICON a service provider tied to the steady demand for drug development and clinical testing.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more